Skip to main content
MyCapitol LogoMyCapitol

HR 9687 · 117th Congress

Medical Innovation Act of 2022

This bill creates a new fee that pharmaceutical companies must pay if they've settled legal cases with the federal government and make blockbuster drugs that benefited from government-funded research. Specifically, it targets large drug manufacturers that have paid settlements for violations like fraud, false claims…

Sponsor
Welch, Peter (D-VT)
Introduced
2022-12-22
Policy area
Health
Latest action
Referred to the House Committee on Energy and Commerce.

Digging through Congress... 🔍